Study on the Effect of DRG and Clinical Pathway on the Coordinated Development of Antibiotics Use Density

Tian Di; Zhou Dian; Zhou Yuan

Abstract：Objective To explore the influence of the coupling and coordination of DRG and clinical pathways on Antibiotics Use Density.Methods The data of 7 clinical departments in a sample hospital from 2021 to 2022 were selected,the data were collated through descriptive statistics,and the coupling coordination degree model was used to measure the coordinated development level of DRG and clinical pathways.Taking the per-average drug cost and the average hospital stay of patients as the threshold variables,the threshold regression model was used to calculate the threshold value of Antibiotics Use Density at the level of coordinated development.Results There was a single threshold(F=21.98,P<0.05)of 6334.69 and a double threshold(F=160.53,15.99,P<0.1)of 6.74 and 8.20 for the average length of stay of patients.The statistical values between the level of coordinated development and Antibiotics Use Density in the two threshold variables were positive.Conclusion There is a nonlinear relationship between the level of coordinated development of DRG and clinical pathway with Antibiotics Use Density,and there is a positive promotion effect,and there are differences in the impact size in different threshold variable intervals.Medical institutions should pay attention to the nonlinear relationship,make good use of hospital informatization,do a good job in reasonable monitoring,and reasonably promote the management of antimicrobial drugs.